The QualityStocks Daily Wednesday, May 18th, 2022

Today's Top 3 Investment Newsletters

SmallCapRelations(CMGR) $0.0141 +56.67%

QualityStocks(AFI) $0.4300 +45.96%

SeriousTraders(PQEFF) $0.2980 +14.82%

The QualityStocks Daily Stock List

Salarius Pharmaceuticals (SLRX)

StockMarketWatch, Stocks That Move, QualityStocks and MarketBeat reported earlier on Salarius Pharmaceuticals (SLRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) (FRA: FP11) is a clinical stage biotechnology firm that is engaged in the development of cancer treatments that are epigenetic-based. Epigenetic refers to the regulatory system that influences gene expression.

Salarius Pharmaceuticals Inc. operates in the biotechnology industry, under the healthcare sector and is based in Houston, Texas. The firm, which was known as Flex Pharma Inc. before changing its name has been granted Product Development Award funding that totals $18.7 million by the Cancer Prevention and Research Institute of Texas in addition to other funding by the National Pediatric Cancer Foundation for the advancement of the Ewing sarcoma clinical program. Salarius Pharmaceuticals Inc. serves consumers and patients in the U.S. and was established in 2014.

Salarius Pharmaceuticals is party to strategic partnerships with the Cancer Prevention and Research Institute of Texas for various activities that entail product development; HLB Life Sciences for the development, manufacture, production and sale of the SP-2577 candidate in South Korea and the University of Utah Research Foundation for the license to patent rights that protect SP-2577 and associated compounds.

Salarius Pharmaceuticals Inc.’s product pipeline includes its lead candidate; seclidemstat, which is undergoing a phase 1/2 clinical trial for relapsed or refractory Ewing sarcoma. The candidate, which is also known as SP-2577, is also undergoing phase 1/2 clinical trials that evaluate its efficacy in treating advanced solid tumors, including ovarian, breast and prostate cancers.

As of 2020, the firm’s SP-2577 candidate had been awarded Rare Pediatric Disease Designation, Orphan Drug Designation and Fast Track Designation by the FDA. Seclidemstat employs a new approach to treat/improve Ewing sarcoma, which will not only benefit patients by addressing a previously unmet medical need but also extend the firm’s reach in the market, which will be good for its growth and investment opportunities.

Salarius Pharmaceuticals (SLRX), closed Wednesday's trading session at $0.217, up 20.6226%, on 1,790,266 volume. The average volume for the last 3 months is 1.767M and the stock's 52-week low/high is $0.16/$1.51.

Armstrong Flooring (AFI)

InvestorPlace, MarketBeat, StockMarketWatch, Zacks,, Trades Of The Day, Market Intelligence Center Alert, QualityStocks, StreetInsider, Daily Trade Alert, The Online Investor, The Street, TradersPro, Trading Concepts, Kiplinger Today, Wealth Insider Alert and StocksEarning reported earlier on Armstrong Flooring (AFI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Armstrong Flooring Inc. (NYSE: AFI) (FRA: 2AS) is focused on designing, manufacturing, sourcing and selling resilient flooring products.

The firm has its headquarters in Lancaster, Pennsylvania and was incorporated in 1860. It serves consumers across the globe, with a focus on the Pacific Rim and North America and has fifteen companies in its corporate family.

The company responsibly and safely operates 7 manufacturing facilities across the globe and works to provide the highest levels of innovation, quality and services. It operates through the Wood flooring and Resilient flooring segments. The former segment is involved in the provision of branded hardwood flooring products that include the Bruce and Armstrong brands, which are used in residential renovations and construction, as well as in commercial applications in offices, restaurants and stores. On the other hand, the latter segment is engaged in designing, manufacturing, sourcing and selling floor coverings, which are mainly used in commercial and home buildings, under the Armstrong brand. The majority of the company’s revenue is derived from the United States.

The enterprise’s products are used in the renovation and construction of institutional, residential and commercial buildings. It sells its products to homeowners, property management firms, installers, contractors, builders, retailers and independent wholesale flooring distributors.

The firm recently reported its financial results for the second quarter of 2021, which show an increase in top line growth. Its CEO noted that they were focused on transforming the company into a more resilient business for its shareholders, employees and customers, which would have a positive effect on the company’s growth, as well as bring investments into the firm.

Armstrong Flooring (AFI), closed Wednesday's trading session at $0.43, up 45.9606%, on 51,240,326 volume. The average volume for the last 3 months is 50.032M and the stock's 52-week low/high is $0.1337/$6.62.

Vroom Inc. (VRM)

InvestorPlace, Schaeffer's, StocksEarning, MarketBeat, Trades Of The Day, The Street, StreetInsider, Daily Trade Alert, The Online Investor, QualityStocks, Early Bird and CNBC Breaking News reported earlier on Vroom Inc. (VRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vroom Inc. (NASDAQ: VRM) (BMV: VRM) is an end-to-end e-commerce platform which operates as a used automotive retailer, allowing individuals to sell and buy used vehicles.

The firm has its headquarters in New York and was incorporated in 2012 by Marshall Chesrown, Richard Williams, Mike Welch, Allon Bloch, Elie C. Wurtman and Kevin P. Westfall. Prior to its name change in July 2015, the firm was known as Auto America Inc. It operates as part of the automobile dealers’ industry, under the consumer cyclical sector. The firm has forty-one companies in its corporate family and serves consumers in the United States.

The enterprise operates through the Wholesale, Texas Direct Auto and E-commerce segments. The wholesale segment is focused on the sale of used cars via wholesale auctions while the direct auto segment is involved in the retail sale of used cars and receipt of the funds earned on the sale of value-added products related with vehicle sales. On the other hand, the e-commerce segment is involved in the sale of used cars via the enterprise’s e-commerce platform and collection of the funds earned on the sale of products associated with these sales. The enterprise’s platform facilitates the selling, buying, re-conditioning, transporting, financing, pricing, registering and delivery of used vehicles. It also provides automotive finance via its United Auto Credit Corporation subsidiary.

The company recently released its most recent financial results, which show significant increases in its revenues and profits. It remains focused on evolving its business, improving its unit economics and expanding into other localities, which will have a positive influence on its growth and revenues.

Vroom Inc. (VRM), closed Wednesday's trading session at $1.36, off by 9.3333%, on 17,162,134 volume. The average volume for the last 3 months is 16.953M and the stock's 52-week low/high is $1.08/$46.30.

Sipp Industries (SIPC)

Mina Mar Marketing Group, PennyStocks24, Pumps and Dumps, Epic Stock Picks, OtcWizard, Promotion Stock Secrets, QualityStocks, Penny Stock Circle, Actual Gains, StocksGoneWild, Fortune Stock Alerts, MassiveStockProfits, Stocks Gone Wild,,, SmallCap Network, Stockgoodies, 1-2-3 Stock Alerts, Stock Analyzer, Wallstreetlivechat, SmallCapVoice, Real Pennies and Orbit Stocks reported earlier on Sipp Industries (SIPC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sipp Industries Inc. (OTC: SIPC) is a conglomerate firm that is primarily focused on manufacturing and distributing consumer and commercial products, as well as in technology, imports and exports.

The firm has its headquarters in Costa Mesa, California and was incorporated in 1993, on July 21st. Prior to its name change in April 2007, the firm was known as Promax Communication Inc. It operates as part of the beverages-brewers’ industry, under the consumer retail sector. The firm has two companies in its corporate family and serves consumers in the United States, with a primary focus on consumers in the states of Colorado, Nevada and California.

The company is focused on providing its consumers in the flourishing legal marijuana industry with high quality products. Its objective is to provide the most unique craft brews to all lovers of beer. The company operates through its Major Hemp subsidiary, which is wholly owned.

The enterprise is involved in the development, production and sale of hemp-infused beer. It uses a proprietary non emulsified process to develop products which are higher in bioavailability. The enterprise makes use of both outdoor and indoor methods of cultivation to prepare its products. It also provides a line of advanced plasma lighting solutions for indoor horticulture applications.

The firm recently launched a new product for the cannabis sleep aid market. Its new product, Nano CBN drops, has been formulated to enhance sleep quality. The firm plans to market and distribute this product globally, which will bring in significant revenue and extend its consumer reach.

Sipp Industries (SIPC), closed Wednesday's trading session at $0.0042, off by 1.1765%, on 22,000 volume. The average volume for the last 3 months is 22,000 and the stock's 52-week low/high is $0.0033/$0.0145.

Nektar Therapeutics (NKTR)

StocksEarning, MarketBeat, MarketClub Analysis, The Street, Schaeffer's, InvestorPlace, Top Pros' Top Picks, StreetInsider, Kiplinger Today, Investopedia, BUYINS.NET, Trades Of The Day, Daily Trade Alert, StreetAuthority Daily, TraderPower, SmarTrend Newsletters, StockMarketWatch, Market Intelligence Center Alert, The Wealth Report, Money Morning, TheStockAdvisor, Market Report, StrategicTechInvestor, PennyOmega, InvestorsUnderground, Greenbackers, FeedBlitz, Weekly Wizards, CRWEFinance, Wealth Insider Alert, Barchart, BestOtc, Hit and Run Candle Sticks, SmallCap Network, The Online Investor, PennyToBuck, FreeRealTime, Daily Markets, CNBC Breaking News, CRWEWallStreet, Email Stock Picks, DrStockPick, Daily Wealth, Blaque Capital Stocks, SmallCapNetwork, The Stock Prophet, The Stock Dork, Streetwise Reports, Street Insider, StockHotTips, MarketWatch, StockEarnings, Investment House, RedChip, QualityStocks, OTCReporter, AllPennyStocks,, InvestorsObserver Team and Stockgoodies reported earlier on Nektar Therapeutics (NKTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nektar Therapeutics Inc. (NASDAQ: NKTR) (LON: 0UNL) (FRA: ITH) (BMV: NKTR) is a biopharmaceutical firm that is focused on researching and developing approved partnered medicines and investigational treatments in virology, immunology and oncology.

The firm has its headquarters in San Francisco, California and was incorporated in 1990. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on India and the United States.

The company is party to collaboration agreements with SFJ Pharmaceuticals Inc., Merck, Eli Lilly and Company, Baxalta Incorporated, Bristol-Myers Squibb Company, UCB Pharma, Amgen Inc., Pfizer Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd, AstraZeneca AB, and Takeda Pharmaceutical Company Ltd. The company has additional operations in Hyderabad, India and Huntsville, Alabama.

The enterprise’s product pipeline comprises of a CD122-preferential IL-2 pathway agonist dubbed Bempegaldesleukin, which is undergoing a number of clinical trials testing its effectiveness in treating various indications, including adjuvant melanoma, muscle-invasive bladder cancer, renal cell carcinoma, metastatic melanoma, urothelial cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer and the coronavirus. It also develops NKTR-262 for the treatment of metastatic or locally advanced solid tumor malignancies; NKTR-255, for the treatment of colorectal cancer, multiple myeloma and non-Hodgkin’s lymphoma; and NKTR-358, for the treatment of psoriasis, atopic dermatitis and ulcerative colitis, among other indications.

The company, which recently announced its latest financial results,remains focused on the advancement of its clinical pipeline to help address the unmet needs of patients suffering from a number of severe indications with no cures.

Nektar Therapeutics (NKTR), closed Wednesday's trading session at $3.8, off by 3.5533%, on 2,852,105 volume. The average volume for the last 3 months is 2.817M and the stock's 52-week low/high is $3.52/$19.37.

Kingsoft Cloud Holdings (KC)

Schaeffer's, MarketBeat, StreetInsider, MarketClub Analysis, InvestorPlace and QualityStocks reported earlier on Kingsoft Cloud Holdings (KC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kingsoft Cloud Holdings Ltd (NASDAQ: KC) is a holding firm that is engaged in the provision of cloud computation and cloud storage services to various organizations and businesses.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in January 2012. It operates as part of the software-application industry, under the technology sector. The firm primarily serves consumers in China.

The company’s objective is to become the biggest internet cloud service provider in China. It has designed a reliable and extensive cloud platform which comprises of advanced cloud products, infrastructure and industry-specific solutions across enterprise cloud, public cloud and Internet of things and Artificial Intelligence cloud services. The company mobilizes its resources towards the provision of high quality services and the innovation of its business models.

The enterprise’s product portfolio covers load balancing, cloud server, CDN, cloud physical host, VPN, relational database, cloud DNS, cache, cloud security, tabular database, hosted Hadoop and object storage, etc. It provides enterprise cloud services to consumers in healthcare businesses, public service, financial service and government administration; and public cloud services to consumers in different verticals, including mobile internet, education, e-commerce, AI, video and games. The enterprise also offers AIoT (artificial intelligence and Internet of things) smart living solutions.

The firm, which is focused on driving its development via technology and innovation, recently announced its plans to explore a dual listing of its shares on the Hong Kong Stock Exchange. This will offer its shareholders greater liquidity and position the firm to capture large and growing market opportunities, which will be good for its growth.

Kingsoft Cloud Holdings (KC), closed Wednesday's trading session at $3.51, off by 6.1497%, on 3,682,559 volume. The average volume for the last 3 months is 3.68M and the stock's 52-week low/high is $2.50/$41.14.

Clean Coal Technologies (CCTC)

Greenbackers, AlphaTrade, QualityStocks, PennyStocks24, OTCPicks, Stockpalooza, Willy Wizard,, PennyStockPlayers, The Stock Scout, PennyStockClub, Penny Stock Pros, Penny Stocks On Steroids, Penny Stock Mobsters, Penny Stock General, Orbit Stocks, MyBestStockAlerts, MicrocapVoice, Fast Money Alerts, CoolPennyStocks, OTPicks, Stock Shock and Awe, PremiereStockAlerts, Promotion Stock Secrets, StockRockandRoll,, Stock Traders Chat, StockLockandLoad, Momentum Traders, StockMister, MarketBeat, MadMoneyPicks, MadMoneyAlerts, HotOTC, TooNiceStocks, Wall Street Mover, BullRally, Mad Money Picks, PennyInvest, OTCJournal, PennyTrader Publisher, Penny Invest, Stock Stars, Penny Stock Pinnacle, Stock Rich, Penny Stock Solutions, RedChip, Pumps and Dumps, and StockEgg reported earlier on Clean Coal Technologies (CCTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clean Coal Technologies Inc. (OTC: CCTC) is a coal technology firm that is focused on the development and sale of a patented process which transforms coal with high levels of contaminants and impurities, among other pollution elements, into low polluting fuel.

The firm has its headquarters in New York and was incorporated in 1986, on September 17th. It operates as part of the industrials sector and serves consumers around the globe.

The company owns patented technology which is based on tried and tested industrial components and well-proven science. The technology uses controlled heat to capture and extract moisture and pollutants like mercury and sulfur from coal in a number of stages, transforming it into a more energy-efficient and cleaner-burning fuel before combustion.

The enterprise’s technology portfolio includes Pristine-SA, Pristine-M and Pristine. Pristine-SA is a technology that’s been designed to get rid of all the volatile matter in the feed coal, allowing it to achieve stable combustion by co-firing it with natural gas or biomass while its Pristine-M technology is a low-cost dehydration technology for coal. On the other hand, the enterprise’s Pristine technology is a technology that was developed to eliminate volatile matter and moisture from sub-bituminous and bituminous coals, including lignite, making it cleaner thermal coal. The enterprise provides solutions for coal users involved in steel, power generation, coal-to-liquids or coal-to-gas projects.

The company is focused on restructuring as well as completing and commercializing its second generation plant. This will help bring in additional revenue into the company, thus ensuring its medium-term and long-term success.

Clean Coal Technologies (CCTC), closed Wednesday's trading session at $0.0043, even for the day, on 213,335 volume. The average volume for the last 3 months is 213,335 and the stock's 52-week low/high is $0.0022/$0.0097.

Graphite Bio (GRPH), Penny Stock Buyers, Eastwind Research, KO PENNY STOCKS, Penny Lane Reports, Penny King, ElitePennyStocks, Momentum Hunter, Paragon Report, QualityStocks, Penny Stock Circle, Pumps and Dumps, SmallCap Fortunes,, Wyatt Investment Research, Epic Stock Picks, EpicVIP Group, 1-2-3 Stock Alerts, PennyStocks24, Stock Analyzer, The Stock Scout, TooNiceStocks, StreetAuthority Financial, CRWEPicks, CRWEWallStreet, PennyStockProphet, MiningStockAlerts, PennyPickAlerts, CRWEFinance, Penny Stock Pros, PennyStockClub, Fortune Stock Alerts, Stock Twiter, Investors Alley, MarketBeat, DrStockPick, StockHotTips, PennyOmega, PennyToBuck, StockOnion, AskSlapper, Caesar's Penny Stocks, SecretStockPromo, Investor Spec Sheet, Investor News Source, AlphaPennyStock,, InvestmentHouse, Insider Wealth Alert, AimHighProfits, Information Solutions Group, Wall Street Elite, AnotherWinningTrade, TheTradingReport, AwesomeStockPick, Trade of the Week, AwesomeStocks, Leading Stock Alerts, Breaking Bulls, Buzz Stocks, Chatter Box Stocks, Club Penny Stocks Network, ExclusiveStockPick, Your Stock Alert, Stock Research Newsletter, Stock Exploder, SquawkBoxStocks, SmallCap Network, StockMister, StockProfessors, Psycho Penny Stocks, Pro-Edge, Premier Equity Reports, PlanetPennies, Pinnacle Stock Alerts, PennyStockSpy, PennyStockShark, The Stock Enthusiast, Penny Champions, Market FN and Marquee Penny Stocks reported earlier on Graphite Bio (GRPH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Graphite Bio Inc. (NASDAQ: GRPH) is a gene editing firm that is focused on the development of therapies for severe and life-threatening illnesses.

The firm has its headquarters in South San Francisco, California and was incorporated in June 2017 by Maria Grazia Roncarolo and Matthew Porteus. Prior to its name change in August 2020, the firm was known as Integral Medicines Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on the United States.

The company harnesses high efficiency targeted gene integration in the development of a novel class of therapies that possess the ability to cure an extensive range of severe and life-threatening illnesses. It is developing a new precision gene editing approach for applications that may transform human health.

The enterprise’s product pipeline comprises of a formulation dubbed GPH301, which has been designed to treat a genetic disorder known as Gaucher disease, which causes a glucocerebrosidase enzyme deficiency. It also develops GPH201, to treat X-linked severe combined immunodeficiency syndrome; and a gene-edited autologous stem cell formulation dubbed GPH101, which has been designed to restore normal expression of hemoglobin and correct the mutation known to cause sickle cell disease.

The firm recently announced its latest financial results, with its CEO noting that it remained focused on maximizing the capabilities of its gene-editing platform and advancing its research and development efforts across its pipeline. This will help create shareholder value and increase investments into the firm.

Graphite Bio (GRPH), closed Wednesday's trading session at $2.36, off by 9.9237%, on 394,280 volume. The average volume for the last 3 months is 394,072 and the stock's 52-week low/high is $2.19/$34.00.

Perma-Pipe International Holdings, Inc. (PPIH)

TradersPro, StockMarketWatch, QualityStocks and InvestorPlace reported earlier on Perma-Pipe International Holdings, Inc. (PPIH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Perma-Pipe International Holdings, Inc. is an international leader in pre-insulated piping and leak detection systems for oil and gas gathering, district heating and cooling, and other applications. The Company has extensive engineering and fabrication expertise that it uses to develop piping solutions, which solve complex challenges concerning the safe and efficient transportation of numerous kinds of liquids. The Company previously went by the name MFRI, Inc. It changed its corporate name to Perma-Pipe International Holdings, Inc. in March of 2017. Incorporated in 1993, Perma-Pipe International Holdings is based in Niles, Illinois. The Company’s shares trade on the NasdaqGS.

Perma-Pipe International has operations at eight locations in six countries. A global engineered pipe services company, it provides core competencies in anti-corrosion coatings, insulation solutions, containment systems, leak detection systems, engineering support, field service, and custom fabrication. The Company has greater than 100 years of product manufacturing and service delivery expertise meeting internationally recognized industry standards and ISO 9001 certification.

Perma-Pipe provides high-quality piping systems to lessen bottom-line installation costs. This extends the life of their customers’ piping systems. The Company has its Premier Engineered Series. The Premier Engineered Series provides unique piping features, design and engineering support, and fabrication capabilities for a custom-fit solution.

It also has its PRO Series. It offers design and engineering support with standard piping features and fabrication based on a customer’s specific project budget, goals, and performance requirements. In addition, Perma-Pipe has its Standard Series. Based on an organization’s budget, minimum project requirements, and fast delivery, the Standard Series offers standard piping features and standard design. The Company also has its Specialty products – PermAlert and Engineered Steel Manholes.

Perma-Pipe International Holdings, Inc. (PPIH), closed Wednesday's trading session at $13.73, up 13.6589%, on 56,970 volume. The average volume for the last 3 months is 56,970 and the stock's 52-week low/high is $6.28/$14.9199.

Mereo BioPharma Group (MREO)

StockMarketWatch, MarketClub Analysis, QualityStocks, BUYINS.NET, Real Pennies, TradersPro and MarketBeat reported earlier on Mereo BioPharma Group (MREO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mereo BioPharma Group Plc (NASDAQ: MREO) (FRA: MAH0) is a clinical stage biopharmaceutical firm that is engaged in the acquisition, development and the commercialization of therapeutic treatments of various rare and oncological ailments, focusing on endocrine, respiratory and bone/musculoskeletal indications.

Mereo BioPharma Group has its headquarters in London, the United Kingdom and was founded in 2015. The firm serves consumers across the globe.

Mereo BioPharma Group Plc is part of the biotechnology research services industry and operates in the biotechnology industry in the healthcare sector.

Mereo BioPharma Group Plc’s product candidates include an aromatase inhibitor that was developed for the treatment of hypogonadotropic hypogonadism called BGS-649 or leflutrozole; a kinase inhibitor that recently concluded phase 2 clinical trials to treat severe exacerbations of chronic obstructive pulmonary disease called BCT-197 or acumapimod and an antibody immunoreceptor with ITIM and Ig domains called OMP-313M31 or etigilimab, which is currently undergoing phase 1b clinical trials for the treatment of tumors. The firm also develops OMP-305B83 or navicixizumab, which is currently in phase 1a clinical trials for the treatment of late line ovarian cancer as well as rare ailments product candidates such as MPH-966 or alvelestat, which is currently undergoing a phase 2 clinical trial evaluating its efficacy in treating Alpha-1 antitrypsin deficiency and BPS-804 or setrusumab, which is currently in phase 2b clinical trials for osteogenesis imperfecta treatment.

December 2020 saw Mereo BioPharma Group Plc finalize a license and collaboration agreement with Ultragenyx for its setrusumab candidate. This move could potentially make setrusumab the first approved therapy for osteogenesis imperfecta, which is a devastating and rare disease in both adults and children. If it does get approved, it would be the first therapy for OI which would greatly benefit the patients as well as the companies involved.

Mereo BioPharma Group (MREO), closed Wednesday's trading session at $0.4835, up 12.4419%, on 1,013,967 volume. The average volume for the last 3 months is 1.013M and the stock's 52-week low/high is $0.301/$3.75.

Freeport-McMoRan Inc. (FCX)

MarketClub Analysis, The Street, InvestorPlace, Schaeffer's, Kiplinger Today, SmarTrend Newsletters, StocksEarning, MarketBeat, Barchart, StreetAuthority Daily, StreetInsider, Trades Of The Day, TopStockAnalysts, Money Morning, Investopedia, Daily Trade Alert, Louis Navellier, VectorVest, Zacks,, Trading Markets, ProfitableTrading, The Growth Stock Wire, Daily Wealth, The Wealth Report, TheStockAdvisors, All about trends, Wall Street Elite, StreetAlerts, Top Pros' Top Picks, Streetwise Reports, Leeb's Market Forecast, The Online Investor, TradingMarkets, Market FN, Dividend Opportunities, Market Report, TheStockAdvisor, StockTwits, InvestmentHouse, Investor Guide, Investors Alley, Investment House, Trading Concepts, Wealth Insider Alert, The Best Newsletters, Options Trader Elite, Money and Markets, Market Intelligence Center Alert, InvestorGuide, Wyatt Investment Research, AnotherWinningTrade, Darwin Investing Network, Bourbon and Bayonets, Energy and Capital, Buttonwood Research, Wealth Daily, Trade of the Week, The Motley Fool, Investing Signal, MarketWatch, Investor Update, Profit Confidential, Market Authority, Wall Street Daily, Cabot Wealth, Super Stock Investor, Street Insider, Trading Tips, Stock Research Newsletter, TradingAuthority Daily, Wealthpire Inc., InvestorsUnderground, AllPennyStocks, CNBC Breaking News, Daily Markets, FNNO Newsletters, Uncommon Wisdom, Normandy Investment Research, 24/7 Trader and Weekly Wizards reported earlier on Freeport-McMoRan Inc. (FCX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Investors are rushing back to Africa as the global energy transition continues to take root. The increasing awareness that cobalt and copper are crucial to the global shift toward renewable energy and the risk to secure supply is also driving this move, given that the international copper market is already tight and it’s becoming increasingly difficult to locate new mines.

This area located in Africa between the borders of the Democratic Republic of Congo and Zambia contains one of the richest reserves of minerals in the world, including cobalt for rechargeable batteries and copper for cables and wire. This is the area at the center of this rush by multinational mining companies.

BHP Group, a major mining company, is looking to invest in the area, with Anglo American Plc also announcing that it had entered into a new joint venture last week. BHP recently held talks concerning the purchase of a copper project in Congo owned by Robert Friedland; the project is located near the Kamoa-Kakula mine. This purchase would make BHP the third largest producer of copper by 2024.

Additionally, Barrick Gold, which has criticized the Congolese government publicly, is looking for new projects in both Congo and Zambia while Quantum Minerals Ltd recently approvedan expansion in Zambia.

These announcements make come as a surprise to some, especially since western mining companies have been trying to leave rather than stay in this central African copper belt for years. The shift may have been brought about by Zambian President Hakainde Hichilema’s objective to triple the output of copper from the country in the next 10 years. The Zambian president hopes to woo investors into the country in order to meet this goal.

Chile and Peru, which are both very rich in copper, are also losing investors in the industry who view them as less friendly places to set up shop.

While Australia, European and American mining firms stayed away from the copper belt these past couple of years, Chinese companies invested in the region. The country’s influence is apparent, with the existence of the Congo city of Kolwezi rooted in the exploitation of the mines.

In order to achieve its production targets, Zambia needs to attract about $180 million annually in investments. The country is currently focused on making the environment attractive for global investors in an effort to benefit from the increasing demand for electrification around the globe, in much the same way that oil-rich countries capitalized on the energy boom.

The revived interest in the copper deposits found in some of the regions previously regarded as less desirable shows that major segment players such as Freeport-McMoRan Inc. (NYSE: FCX) could be poised to grow even bigger as their dominance grows as they benefit from this bull market.

Freeport-McMoRan Inc. (FCX), closed Wednesday's trading session at $35.34, off by 6.1105%, on 18,281,690 volume. The average volume for the last 3 months is 18.061M and the stock's 52-week low/high is $30.02/$51.99.

Crexendo Inc.'s (CXDO)

Wall Street Resources, MarketBeat, QualityStocks,, OTC Markets Group, InvestorPlace and Daily Market Beat reported earlier on Crexendo Inc.'s (CXDO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crexendo (NASDAQ: CXDO) is an award-winning provider of enterprise-class cloud communication solutions designed to suite any size business through its partners, software licensees, agents and direct channels. Crexendo’s solutions were recently recognized as the fastest growing unified communications as a service (“UCaaS”) platform in the United States. Providing services through its telecommunications and software solutions divisions, Crexendo has announced that its solutions now support over two and a half million end users globally. “The continued growth gives me great confidence for our future. When we acquired the software solutions division, we knew we would have the best communication platform, together with the best design and engineering teams in the industry,” Crexendo’s CEO Steven G. Mihaylo said in the press release. “The fact that our growth continues to accelerate shows that customers share our opinion. This substantial and sustained growth shows the benefit of the combined organization, the entire team works every day to improve our products and services. Our joint efforts and investments are a benefit both for the software solutions customers and telecom customers. The benefits we provide allows Crexendo to offer our VIP platform, which is an all-in-one cloud business communications solution with a 100% uptime guarantee that offers video collaboration, interactions, and business phone communications for customers of all sizes. This continued growth and increase in users on the fastest growing platform in North America will provide additional revenue and higher margins and profit.”

To view the full press release, visit

About Crexendo Inc.

Crexendo is an award-winning premier provider of unified communications as a service (“UCaaS”), call center as a service (“CCaaS”), communication platform software solutions, video conferencing and collaboration services designed to provide enterprise-class cloud communication solutions to any size business through its business partners, agents and direct channels. With solutions currently supporting over two million end users globally, Crexendo was recently recognized as the fastest growing UCaaS platform in the United States.

Crexendo Inc.'s (CXDO), closed Wednesday's trading session at $3.07, up 2.3333%, on 98,910 volume. The average volume for the last 3 months is 98,910 and the stock's 52-week low/high is $2.10/$7.20.

The QualityStocks Company Corner

BlockQuarry Corp. (OTC: BLQC)

The QualityStocks Daily Newsletter would like to spotlight BlockQuarry Corp. (OTC: BLQC).

Back in 2019, President Xi Jinping made comments during a speech to the effect that China needed to seize the massive opportunities blockchain technology presented. From that time, the country regarded blockchain tech as a priority alongside other technologies such as semiconductors. Since that speech by the Chinese president, the country embarked on a quiet task of building a platform that would make it easy for companies to deploy blockchain technology in their operations. That platform is called Blockchain-based Services Network (“BSN”). It should be remembered that the Chinese government more or less banned cryptocurrencies and other related activities. Why then is it creating a blockchain platform? The answer is simple: the country is creating a blockchain platform for use in other applications other than for cryptocurrencies. Ironically, if China’s BSN succeeds in taking blockchain to the mainstream, it could provide an indirect boost to the widespread interest in the activities of firms like BlockQuarry Corp. (OTC: BLQC) which specialize in blockchain and crypto mining.

BlockQuarry Corp. (OTC: BLQC), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.


The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

BlockQuarry Corp. (BLQC), closed Wednesday's trading session at $0.54025, up 0.981308%, on 104,885 volume. The average volume for the last 3 months is 104,885 and the stock's 52-week low/high is $0.19/$3.78.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GreenBox POS (NASDAQ: GBOX).

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced its participation in the H.C. Wainwright Global Investment Conference. The event is slated to take place in a virtual and in-person format at the Fontainebleau Miami Beach Hotel on May 23-26, 2022. GreenBox Chairman Ben Errez will give a company presentation and will be available for virtual one-on-one meetings with investors. Errez’s presentation is scheduled to begin at 7 a.m. ET on Tuesday, May 24, and will be available on demand. Interested parties should visit to register and view the webcast. To view the full press release, visit

GreenBox POS (NASDAQ: GBOX) is an emerging financial technology company leveraging proprietary security and token technology to build customized payment solutions for business. The company’s mission is to build compliant, cutting-edge blockchain ledger tokenized solutions for the diverse, evolving and dynamic global market.

GreenBox applications enable an end-to-end suite of turnkey financial products which offer improved fraud detection and better handling efficiency of large-scale commercial payment processing volumes for its merchant clients globally. The company’s proprietary blockchain and smart contract token technologies create seamless payment processing using digital encryption keys.

GreenBox is a unified platform providing scalability for businesses to accept payments, transact, send, settle and convert in a single versatile ecosystem. GreenBox operates a private and proprietary blockchain-based payment platform that offers distinct advantages when compared to traditional payment technologies, including greater security and data privacy, as well as enhanced identity theft protection and quick settlement.

As the settlement engine for financial transactions, GreenBox’s blockchain technology is a distributed ledger that uses digitally encrypted keys to verify, secure and record details of each transaction conducted within GreenBox’s private ecosystem. The speed and security of the platform allows GreenBox to log immense volumes of immutable transactional records in real time for Tier-1 partners around the world.

In November 2021, GreenBox announced the closing of a previously announced $100 million convertible note financing. The company plans to use proceeds for acquisitions, a planned stablecoin spin-off, and additional working capital toward the company’s future growth. The initial conversion price equals a more than 80 percent premium to the market price of the company’s common stock on October 29, 2021, and values the enterprise at more than $700 million upon conversion.

Brands & Solutions

The company offers multiple solutions and brands under the GreenBox label. The other brands that are nested under the GreenBox POS label include coyni, ChargeSavvy, QuickCard, Transact Europe [didn’t yet close] and Northeast Merchant Systems. Each of these brands play a large role in allowing GreenBox to accel in customizing payment solutions across different verticals and industries.

Payment Solutions

The GreenBox platform offers blockchain secure, robust payment processing solutions for both individual consumers and businesses. The company combines the power and security of blockchain with bank-level tools necessary to both settle transactions and monitor cash flows. Customers can transfer cryptocurrencies like USDC, Ethereum or Bitcoin from external decentralized crypto wallets to their GreenBox wallets. They can also exchange those tokens from their GreenBox wallets to any supported coin. Customers can easily offload in USDC to a debit card or a multitude of gift cards.

White Label Solutions

The company’s white label platform allows it to partner with firms seeking blockchain-based tools to manage merchant relationships. White label partners can monitor cash flows, as well as run reports on merchant transactions, chargebacks, agent and affiliate commissions and more. Partners can access the platform through their partner portal to manage business relationships with full visibility. The platform’s cutting-edge technology saves partners time and simplifies their payment processing. It ensures compliance with automated Know Your Customer and Know Your Bank services and allows customers to set up automated payouts.

coyni Stablecoin

The company is planning soon to launch its own stablecoin, coyni (CYN). coyni is equivalent to the value of the U.S. dollar on a one-to-one ratio. Stablecoin allows for instantaneous transactions with blockchain security just like other cryptocurrency tokens, but without the price volatility of traditional cryptocurrencies. The CYN token is expected to make possible features like digital dollar accounts, cross border payments, international payment processing and other payment solutions. As a smart contract technology, coyni will offer instant settlement using the GreenBox blockchain ledger in any location and currency – crypto or fiat – all at lower fees and in a tokenized secure ecosystem.

Market Overview

A Mordor Intelligence report put the transaction value of the global digital payments market at $5.44 trillion in 2020 and projects the market to be worth $11.29 trillion by 2026. That represents a CAGR of 11.21 percent during the period of 2021-2026.

The report notes that the global COVID-19 pandemic and its impact on e-commerce is likely to encourage strengthened international cooperation and further development of policies for online purchasing and supply. The report states, “The pandemic has made it clear that e-commerce can be an important tool/solution, especially considering the fact that e-commerce sales can support small and medium businesses that form the backbone for certain economies. This is expected to substantially spur the growth of digital payment methods across various economies.”

According to Mordor, other drivers of the growth trend in digital payments include:

  • Greater convenience, favorable government policies and evolving consumer behavior worldwide
  • Rapid rise in smartphone penetration throughout emerging economies
  • Introduction of mobile wallets across the world
  • Widespread adoption of retail digital payment services across the vast population of China, serving as a kind of test case for other countries

Management Team

Ben Errez, Chairman of the Board of Directors

Ben Errez’s past positions have included positions at large companies like Microsoft and Intel. He has brought this expertise to lead GreenBox into the forefront of the blockchain-based financial software, services, and hardware market.

Mr. Errez was one of the early managers of Microsoft in 1991. From 1991 to 2004, he served as Software Development Lead for the Microsoft International Office Group. He led the International Microsoft Office Components team (Word, Excel, PowerPoint) in design, engineering, development, and successful deployment. He also served as Executive Representative of Microsoft Office and was a founding member of the Microsoft Trustworthy Computing Team both within the company and internationally. Mr. Errez co-authored the first Microsoft Trustworthy Computing Paper on Reliability. At Microsoft, he was responsible for the development of the first Microsoft software translation Software Development Kit (“SDK”) in Hebrew, Arabic, Thai, and Simplified Chinese, as well as the development of the first bidirectional extensions to Rich Text Format (“RTF”) file format and all bidirectional extensions in text converters for Microsoft Office. He also contributed to the development of the international extensions to the Unicode standard to include bidirectional requirements under the World Wide Web Consortium (“W3C”).

In 2004, Mr. Errez transitioned into the world of consulting, where he held the position of Principal Consultant from founding to the present date, through which he advises clients in the South Pacific region with market capitalizations ranging from $50 million to $150 million on commerce, security, reliability, and privacy.

In 2017, immediately before partnering with Fredi Nisan to launch GreenBox, Mr. Errez was asked to take over the Microsoft Alumni Network for the Southern California region as a regional director. Mr. Errez has been a principal of GreenBox since its inception in 2017.

Fredi Nisan, Chief Executive Officer

Fredi Nisan’s career in technology began during his years of service in the Israeli Defense Forces, where he served as IT Manager for all of Israel’s Northern Bases. After serving in the military, Mr. Nisan opened and operated a computer hardware store before becoming the Inventory Operations Manager for Zicon Israel in 2005, a hardware and software producer. At Zicon, he supervised inventory operations, worked on quality controls for motherboards and chips, and educated customers on software and hardware product functionality. Subsequently, Mr. Nisan moved to the United States, where he worked for One Coach in San Diego, California, as a business coach. One Coach specializes in customized growth solutions for small business owners, including the latest strategies for sales, internet marketing, branding, and ROI. Mr. Nisan was consistently ranked as the top salesperson for small business coaching while working with One Coach.

In 2010, Mr. Nisan launched Brava POS, where he served as President until 2015. Brava POS provided point of sale (“POS”) systems for specialty retail companies. Mr. Nisan developed software to provide clients with solutions for issues ranging from inventory management to payroll to processing high volume transactions in the form of a cloud-based POS system. This system had the capability to manage multiple stores with centralized inventory and process sales without an internet connection, and offered a secure login for each employee, as well as including advanced inventory management and reporting, plus powerful functionality for its end users.

In 2016, Mr. Nisan founded Firmness, LLC. Through Firmness, he created “QuickCitizen,” a software program that simplifies the onboarding process for new clients of law firms specializing in immigration issues. The QuickCitizen software significantly reduced law firms onboarding processing time from more than three hours to approximately 15 minutes. Mr. Nisan has been a principal of GreenBox since its August 2017 inception. In January 2018, Firmness sold QuickCitizen to GreenBox.

Jacquline B. Reynolds, Chief Marketing Officer

Jacqueline B. Reynolds is the company’s Chief Marketing Officer. She served most recently as vice president of marketing for Sprouts Farmers Market. She has built her reputation as a world-class global marketer, working with Coca-Cola, McDonald’s, Verizon, Walmart, L’Oréal, Xbox, 7-Eleven and many other Fortune 500 brands. She has managed award-winning marketing programs with partners such as the NFL, Super Bowl LIV, the Olympics, the FIFA World Cup, Sony Pictures, Universal Music and others.

GreenBox POS (NASDAQ: GBOX), closed Wednesday's trading session at $2.24, up 12%, on 1,011,174 volume. The average volume for the last 3 months is 1.011M and the stock's 52-week low/high is $1.65/$16.50.

Recent News

Home Bistro Inc. (OTC: HBIS)

The QualityStocks Daily Newsletter would like to spotlight Home Bistro Inc. (OTC: HBIS).

Home Bistro (OTC: HBIS), a Miami-based online meal delivery platform that offers celebrity chef-inspired and ready-made meals, is on a mission to lead the next generation of heat-to-eat food delivery with unique and delicious cuisine and an experience that excites the market. Home Bistro offers a family of high-quality, direct-to-consumer, gourmet meals, addressing the three problems facing the prepared food delivery market: poor food quality; customers tired of eating the same meals; and the fact that eating at home is still eating at home, with the accompanying food preparation and clean up chores. “In mid-2021, Home Bistro acquired southern-California based Model Meals, a lifestyle ready-to-eat meal prep service, which is Whole30 and Paleo approved, while then only serving three states. In September 2021, Home Bistro commenced shipping Model Meals to all 50 states and recently announced that it will launch a subscription-based service for Model Meals consisting of three meals per day (breakfast, lunch and dinner) for up to five days per week,” a recent article reads. “Home Bistro has partnered with celebrity chef Melanie Moss to expand its dessert menu options... The company has worked diligently with the team at In Good Taste Wines [a direct-to-consumer platform] to develop a unique selection of elegant single-serving wines to pair with Home Bistro’s celebrity chef-inspired meals. The partnership with In Good Taste Wines provides Home Bistro with a low-cost, incremental source of revenue, which will assist the company in expanding its gross profit margin and lead it to faster profitability.” To view the full article, visit

Home Bistro Inc. (OTC: HBIS) is a Miami-based company engaged in the business of providing prepackaged and prepared meals to consumers. The company has created the next generation of prepared meal delivery – Ready-Made Gourmet Meal Delivery 3.0.

Home Bistro addresses the three major problems facing the prepared food delivery market: poor food quality; customers tired of eating the same meals; and, eating at home is still eating at home, with the accompanying food preparation and clean up chores. The company addresses these problems by delivering high quality food fresh and fast, providing customers a variety of meal choices from a diverse lineup of celebrity chefs, and requiring simple prep and easy clean up without sacrificing the fine dining experience.

Home Bistro offers a family of high quality, direct-to-consumer, ready-made, gourmet meals. Using the latest fresh food “skin-packing” technology, Home Bistro offers a virtual “Bistro Emporium” where consumers can cross select from a wide variety of siloed “bistros,” each with a dedicated section and unique visitor experience created by a renowned celebrity/executive chef. Meals delivered fresh can be eaten within 10 to 14 days or frozen for up to six months.

The company’s mission is to lead the next generation of heat-to-eat food delivery with unique and delicious cuisine and an experience that excites the market. Home Bistro’s advantage in the highly competitive meal delivery space is meal diversity – with the best celebrity chefs from around the world, offering a home-based fine dining experience through a selection of over 50 unique gourmet meals, as well as offering a developing selection of desserts and single-serving wine to perfectly complement the meal experience. In addition, the company uses only the highest quality ingredients in its meals and preserves their freshness by employing state-of-the-art vacuum skin packing.

In mid-2021, Home Bistro acquired southern-California based Model Meals, a lifestyle ready-to-eat meal prep service, which is Whole30 and Paleo approved, while then only serving three states. In September 2021, Home Bistro commenced shipping Model Meals to all 50 states and recently announced that it will launch a subscription-based service for Model Meals consisting of three meals per day (breakfast, lunch and dinner) for up to five days per week. The subscription service, expected to launch by May 2022, will initially target the Southern California market, where Model Meals maintains a food production and fulfillment facility and enjoys a strong customer base.

Brands and Products

Home Bistro’s leading online platform ( provides direct-to-consumer, heat-to-eat, celebrity chef-inspired gourmet meals. Offerings currently include inspirations developed by “Iron Chef” Cat Cora, two-time New York Times best-selling cookbook author and TV host Ayesha Curry, sports-tailgating focused creator of “Hungry Fan” Chef Diana Falk, “Master Chef” Claudia Sandoval, and “Top-Chef All-Star” Richard Blais. Soon-to-launch celebrity chefs on the Home Bistro platform include “Caterer to the Stars” Roblé Ali, “zero-waste cooking” celebrity chef Priyanka Naik, and CHOPPED champion Melanie Moss.

Home Bistro’s Model Meals lifestyle brand ( is a Whole30 and Paleo approved, ready-to-eat meal prep service, offering a weekly rotating menu that is prepared by professional chefs, using only the highest quality ingredients available, sourced responsibly and locally, and delivered in sustainable, eco-friendly packaging.
Home Bistro has partnered with celebrity chef Melanie Moss to expand its dessert menu options. In keeping with its mission to deliver a complete gourmet culinary experience to discerning customers, Home Bistro beta-tested its first dessert – a delicious, sweet and salty caramel brownie. Based on the encouraging results, the company is moving forward to create a much more robust dessert menu.

Home Bistro has formally launched its wine offering initiative with In Good Taste Wines, a unique direct-to-consumer wine platform that empowers wine lovers to “discover the world, by the glass.” The company has worked diligently with the In Good Taste Wines team to develop a unique selection of elegant single-serving wines to pair with Home Bistro’s celebrity chef-inspired meals. The partnership with In Good Taste Wines provides Home Bistro with a low-cost, incremental source of revenue, which will assist the company in expanding its gross profit margin and lead it to faster profitability.

Market Outlook

Global revenue in the online food delivery sector was $136 billion in 2020 and forecast to grow steadily at a 7.5% CAGR through 2024 to a projected value of $182 billion.
In the U.S., the food delivery sector, which comprises both the restaurant-to-consumer segment and the platform-to-consumer segment where Home Bistro operates, is expected to surpass $32.3 billion in 2024. The company’s addressable market, the platform-to-consumer segment, is approximately 30% of the U.S. market and is projected to reach a value of $9.7 billion by 2024. This segment is expected to grow even faster than the sector as a whole as providers refine their focus on healthier meals, more convenient delivery and subscription options and more advanced meal processing technology.

Management Team

Zalmi Duchman is Chairman and CEO at Home Bistro. He was CEO and founder of The Fresh Diet online meal delivery service, which grew from a startup to over $30 million in annual revenue. He is a thought leader, investor and publisher of numerous articles in the food tech sector. He was named one of Forbes “America’s Most Promising CEOs Under 35,” and was named a Miami Herald “20 Under 40” entrepreneur in 2014.

Carlo Ricci is Director of Operations at Home Bistro. He was VP Operations for The Fresh Diet online meal delivery service, where he developed the culinary and R&D departments and established distribution centers in five states. He was also Operations Manager at Homemade Meals, where he developed and implemented inventory systems, established production facilities on both coasts and trained and managed personnel. He has a bachelor’s degree in data analytics from Miami Dade College.

Camille May is CFO at Home Bistro. She is a co-founder of Model Meals meal delivery service, where she has served as CFO since the company’s inception in 2015. She helped build the company from the ground up to more than $2 million in annual revenue. Prior to Model Meals, she worked as a financial analyst and broker in commercial real estate. She has a BBA in finance from the Leeds School of Business at the University of Colorado.

Danika Brysha is Chief Marketing Officer at Home Bistro. She co-founded Model Meals and was also a co-founder of the Self-Care Society. She is a former fashion model and founder of Danika Brysha Inc., a service specializing in modeling, coaching, speaking, events, media and influence. She is creator of the Brunch Series and a Whole30 certified coach. She is also host of the top-rated podcast “Light + Life Live” and is a lifestyle design expert. She earned a bachelor’s degree from the University of Colorado.

Home Bistro Inc. (OTC: HBIS), closed Wednesday's trading session at $0.46, off by 11.5385%, on 500 volume. The average volume for the last 3 months is 500 and the stock's 52-week low/high is $0.15/$1.98.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced acceptance of its abstract for poster presentation at the American Society of Clinical Oncology (“ASCO”) 2022 Annual Meeting. Being held virtually and in Chicago, Illinois, the event is slated to take place from June 3-7, 2022. The abstract is titled “Design and initiation of an adaptive, randomized, controlled study of berubicin, a topoisomerase 2 poison that crosses the blood brain barrier (‘BBB’), for the treatment of recurrent glioblastoma multiforme (‘GBM’) after first-line therapy.” Sandra L. Silberman, M.D., Ph.D., chief medical officer of CNS Pharmaceuticals, is the presenter in the “Poster Session/Central Nervous System Tumors” scheduled from 8 a.m. to 11 a.m. CT on Sunday, June 5, 2022. To view the full press release, visit

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $0.2861, up 0.952717%, on 525,695 volume. The average volume for the last 3 months is 523,571 and the stock's 52-week low/high is $0.2453/$2.68.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

  • Bigga$tate, a Fan Pass Live artist, will be kicking off his tour with a performance at the Iowa Summer Jam Festival, with Fan Pass Live as an exclusive sponsor
  • Since acquiring Artist Republik and FeaturedX, Friendable has created the ultimate “anti-label” 360 artist platform
  • Artists benefit from all aspects of the music industry without the record label control – including distribution to platforms such as SoundCloud and Spotify

Friendable (OTC: FDBL), a mobile technology and marketing company, is announcing the next steps and growth of an artist relationship that began in December 2020, blossoming from the nurturing support of the Fan Pass Live team, technology, and current 360 artist offering. Since the successful acquisition of Artist Republik and FeaturedX in January 2022, Friendable has created the ultimate “anti-label” offering for independent artists looking to remain in control of their music. Artist Bigga$tate gives the team accolades for their support – having chosen the platform for his exclusive streaming, merchandise, and content partner. Bigga$tate will be a part of the Iowa Summer Jam Festival, which kicks off his tour on June 11, 2022, in which Fan Pass Live and its 360 artist platform will be an exclusive sponsor (

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Wednesday's trading session at $0.000342, off by 12.3077%, on 18,152,900 volume. The average volume for the last 3 months is 18.153M and the stock's 52-week low/high is $0.0003/$0.0188.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

  • Eat Well Investment Group Inc. is a plant-based foods focused investment company dedicated to helping consumers pursue healthier food options while sustaining global food security
  • Eat Well’s investments include subsidiaries Belle Pulses, Sapientia and Amara Organic Foods and establish a portfolio of plant-based food production companies targeting protein alternative and natural baby food markets
  • Distribution agreements with companies such as Walmart, Whole Foods, Sprouts Farmer’s Market, Loblaws and HEB Grocery Company (H-E-B) are making it possible for Eat Well’s investee companies to rapidly increase their consumer reach
  • The company recently announced developments in a special warrant indenture that will trade on the Canadian Securities Exchange through December 2024 as part of its efforts to welcome new investment

When Sodexo Campus, the college and university arm of international foodservice giant Sodexo, announced this month that it will expand its plant-based menu items to 42 percent of the total meals it offers at hundreds of universities across the United States, it heralded the growing importance consumers place on earth-friendly, nutritious plant-based foods, as noted by industry e-magazine Veg News (

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.


On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Wednesday's trading session at $0.2287, up 6.3474%, on 15,451 volume. The average volume for the last 3 months is 15,451 and the stock's 52-week low/high is $0.186/$1.00.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, on Tuesday announced several new hires across vehicle engineering, vehicle integration, powertrain systems and manufacturing in support of EV vehicle programs. Mullen’s CEO and Chairman David Michery indicated that each of the individuals is vital and will be located across the company’s different facilities in California and Mississippi, Mullen’s Powertrain in Monrovia, and Mullen’s AMEC Manufacturing. “I am happy to announce the addition of these new members to the Mullen Automotive Team,” Michery said. “Every new team member is a vital hire and an integral part of our EV programs and bright future for Mullen Automotive.” To view the full announcement, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $1.05, off by 7.8947%, on 40,826,080 volume. The average volume for the last 3 months is 40.826M and the stock's 52-week low/high is $0.52/$15.90.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

  • Violent crime in the United States grew at a record percentage rate during 2020
  • The autonomous security robots developed by Silicon Valley-based Knightscope are designed to help deter criminal activity by helping bad actors to recognize that their misbehavior may be observed and recorded to be used against them
  • Knightscope has been in operation for over 1.5 million hours and has produced three robotic models adaptable to a variety of client facility needs
  • The company has recorded a number of crime-intervention successes, and recently reported its first contract with a Las Vegas casino property to help protect the business’s guests

A historic drought in the western United States has revived interest in the “Godfather” era of the Mafia, after water levels in the power-supplying Lake Mead reservoir east of Las Vegas fell sharply to a point that a couple of long-submerged bodies were exposed — one of them in a rusted barrel. “There’s no telling what we’ll find in Lake Mead,” former Las Vegas Mayor Oscar Goodman told media outlets ( “It’s not a bad place to dump a body.” While the former mayor’s quip reflects a macabre amusement over the discoveries, the serious realities surrounding homicides are reflected in concerns over government data that the country’s murder rate rose at what appears to be the largest year-over-year percentage since comprehensive records began to be kept more than a century ago — and parallel reporting that the overall murder rate nonetheless remains well below what it was in the 1970s, when the recently found bodies in Las Vegas likely met their fate ( “Experts have pointed to a variety of potential causes, including the economic and societal changes brought on by the coronavirus pandemic and changes in police-community relations after the murder of George Floyd in Minnesota last year. But the exact reasons remain unclear,” John Gramlich wrote for the Pew Research Center’s report on the data ( Autonomous Security Robot (“ASR”) developer Knightscope (NASDAQ: KSCP) has built its business on the belief that ever-present vigilance can help further the reduction of a variety of crimes, including violent incidents, by helping bad actors to realize that their misdeeds may be watched and recorded. 

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Wednesday's trading session at $3.58, off by 3.7634%, on 139,273 volume. The average volume for the last 3 months is 138,747 and the stock's 52-week low/high is $3.52/$27.50.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

The National Institutes of Health (NIH) has published a notice calling on interested researchers to apply for funding to facilitate studies related to the role cannabis can play in various aspects of cancer treatment. In that notice, the federal agency revealed that one out of every four patients with cancer report using marijuana products in order to manage the symptoms they experience. These symptoms include pain, nausea and anorexia. However, NIH points out that despite these reasons for using marijuana, there is scant research about its efficacy and any potential risks that the cancer patients may be exposing themselves to. The funding is therefore intended to promote studies geared at understanding the different mechanisms through which cannabinoids and cannabis in general influence cancer biology, interception and treatment as well as cancer resistance. Studies looking into oncology symptom management also qualify for the federal funding. As more data becomes available about the therapeutic effects of marijuana, companies that make products easing the cultivation of this and other plants, such as Advanced Container Technologies Inc. (OTC: ACTX), could register a surge in demand as more jurisdictions permit cannabis home grows.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Wednesday's trading session at $0.85, off by 2.9126%, on 4,890 volume. The average volume for the last 3 months is 4,890 and the stock's 52-week low/high is $0.66/$4.55.

Recent News

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, and its founder and CEO Eric Weisblum are the center of attention in the most recent episode of the Bell2Bell Podcast. The Bell2Bell Podcast is designed to provide informative updates and exclusive interviews with executives operating in fast-moving industries. During the interview, hosted by Stuart Smith, Weisblum talks about his own background and experience in the industry as well as Silo Pharma’s business model and the company’s recent milestones. Weisman has been building and managing businesses for more than two decades and has served on the boards for several public companies; he also has garnered impressive experience in licensing technologies out of universities. “Silo Pharma is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Parkinson’s and other rare neurological disorders,” said Silo Pharma founder and CEO Eric Weisblum in the press release. “We typically identify assets and look to partner with academic universities to advance their research with the goal of developing therapeutics to help patients down the road. In 2021, we were able to license some very exciting technology and start advancing the research and development. . . . We have some technology in a partnership with Columbia University and University of Maryland, Baltimore, and we look forward to getting some data this year from the studies that we have initiated.” To hear the full interview, visit To view the full press release, visit A number of clinics in various cities in America have received approval from the FDA to expand patients’ access to MDMA. MDMA is a psychedelic drug commonly referred to as ecstasy. Researchers have found that this drug may be useful in the treatment of a number of mental health conditions, including post-traumatic stress disorder, or PTSD. While this program is currently in phase III trials, the effectiveness and safety demonstrated thus far will enable the drug to be used for compassionate use. Compassionate use is an approval term used by the FDA for treatments that may help patients who haven’t benefited from conventional treatment options. As the use of psychedelics as therapeutic agents grows, there is likely to be a flurry of subsequent approvals for many other such treatments commercialized by companies that are currently engaged in conducting their own R&D, such as Silo Pharma Inc. (OTCQB: SILO).

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.


Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Wednesday's trading session at $0.14865, up 2.4466%, on 8,950 volume. The average volume for the last 3 months is 8,950 and the stock's 52-week low/high is $0.12/$0.2979.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, is hosting a webinar focused on the global cannabis regulatory landscape; the event is scheduled for Thursday, May 19, at 4 p.m. EDT. Titled “The State of the Play: Cannabis Regulatory Landscape,” the webinar will feature Flora Growth executives, including president and CEO Luis Merchan, COO Jason Warnock and newly appointed VP of regulatory affairs Holly Bell. The webinar agenda includes an overview of the opportunities and challenges facing Flora and other cannabis companies operating in the United States, Colombia and other global markets; the importance of working closely with government entities will also be discussed. In addition, Bell will be speaking at Florida’s Industrial Hemp Conference and Exhibition, slated for May 20, 2022. This premier event explores the progress of the industrial hemp industry in Florida and across the United States. Bell will discuss Florida’s hemp program, which she worked with state regulators to develop. Flora Growth also announced that Vessel, its cannabis accessories brand, is partnering with Highsman. A cannabis lifestyle brand, Highsman was created by former NFL running back Ricky Williams to celebrate greatness. The first offering from the partnership is a custom Highsman-branded and designed Helix one-hitter accessory made from pure, nontoxic brass. The design, which is patent pending, features an ideal combination of filtering and cooling. “Ricky Williams’ distinct personal style is reflected in the unique design of the Highsman Helix,” said Flora Growth chief strategy officer and Vessel president James Choe in the press release. “Ricky’s story personifies the authenticity and individuality that exists at the core of Vessel, and this collaboration is a true representation of the freedom to be original.” To register for the webinar, visit To register for the conference, visit To view the full press releases, visit and

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.


Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Wednesday's trading session at $1.2, off by 8.3969%, on 460,232 volume. The average volume for the last 3 months is 459,532 and the stock's 52-week low/high is $1.10/$21.45.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding participation of its CEO Matt Stang at the H.C. Wainwright Annual Global Life Sciences Conference taking place May 23-26, 2022, in Miami, Florida. The four-day event will feature keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment. At this year's conference, Stang will present the company's expansion strategy and participate in one-on-one meetings. Interested parties should visit to register for the event. To view the full press release, visit Senators Cory Booker and Brian Schatz are calling for federal agencies to provide updates on studies into the therapeutic potential of psychedelic substances. In a letter penned to the top officials at the FDA and the National Institutes on Health, the senators stated that the agencies were crucial to ensuring a rigorous and comprehensive science-based approach to research on psychedelics. The senators stated that they are encouraged that the National Institutes of Health held a workshop earlier this year to look into the regulatory challenges that are hindering research into psychedelic substances, including MDMA and psilocybin. The senators, who argued that ongoing federal prohibition had stymied research on the drugs, added that they wanted these federal agencies to expand their role in identifying regulatory hurdles in the psychedelic research field and possible therapeutic uses of psychedelic drugs as well as research gaps. The DEA even increased quotas for the production of some psychedelic drugs, including psilocybin, in a bid to promote research into the substance. This would be a good way to appreciate the strides taken by psychedelic sector actors such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), which are already offering ketamine treatments while also furthering research into other psychedelic compounds.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Wednesday's trading session at $0.0476, up 24.9344%, on 45,268 volume. The average volume for the last 3 months is 45,268 and the stock's 52-week low/high is $0.03308/$0.315.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.